YB
Yuanbao Inc. American Depositary Shares
About: Yuanbao Inc is a technology-driven online insurance distributor in China.
–
Funds holding %
of 7,327 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for YB.
Financial journalist opinion
Negative
Seeking Alpha
1 month ago
Yuanbao: Could Be A Good Time To Get In Due To Trade Uncertainty
YB did not exactly get off to a roaring start post-IPO, which may have come as a disappointment, but the stock has been moving higher in recent days. The stock may not reflect it, but the top and the bottom line are growing to the point that YB can be seen as undervalued. The stock's rather tepid performance probably did not happen by accident, and it is possible YB may regress in this regard due to U.S.-China relations.

Neutral
GlobeNewsWire
1 month ago
Yuanbao Inc. Announces First Quarter 2025 Unaudited Financial Results
BEIJING, June 05, 2025 (GLOBE NEWSWIRE) -- Yuanbao Inc. (“Yuanbao” or the “Company”) (NASDAQ: YB), a leading technology-driven online insurance distributor in China, today announced its unaudited financial results for the first quarter ended March 31, 2025.

Neutral
Seeking Alpha
3 months ago
U.S. IPO Weekly Recap: Flurry Of SPACs List And Submit Filings Amid Otherwise Quiet IPO Market
Two IPOs and nine SPACs debuted this week. One IPO and six SPACs submitted initial filings. A handful of IPOs are scheduled to price in the week ahead, led by two sizable insurers.

Neutral
Seeking Alpha
3 months ago
U.S. IPO Weekly Recap: Small Foreign Issuers List In The U.S. As Notable IPOs Continue To Delay
A handful of small issuers listed in the US this past week, joined by four SPACs. Two IPOs are set to list in the week ahead, although some deals may move around the calendar at the last minute. Street research is expected for five companies in the week ahead.

Positive
Seeking Alpha
10 months ago
Yuanbao Readies U.S. IPO On Fast Growth And Profits
Yuanbao Inc. seeks to raise $50 million in a U.S. IPO to fund growth, enhance technology, and expand its consumer reach in China. The firm has shown strong revenue growth, increasing profits, and impressive cash flow, though growth is decelerating and CapEx spending is unusually low. Yuanbao faces regulatory risks due to its VIE structure and the unpredictable Chinese regulatory environment, impacting its stability.

Charts implemented using Lightweight Charts™